SEC Form 4 · accession 0000310354-26-000068
STANDEX INTERNATIONAL CORP/DE/ · SXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michelle Newbury
Officer — Chief HR Officer & VP
Period of report
Aug 21, 2026
Accepted (ET)
Aug 25, 2026 · 3:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000310354
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2026 | M | 126 | — | A | 756 | D | |
| Common Stock | Aug 21, 2026 | F | 36 | $310.28 | D | 720 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | — | Aug 21, 2026 | M | 126 | D | — | — | Common Stock | 126 | 252 | D |
| Phantom Stock UnitsF3 | — | Aug 23, 2026 | A | 360 | A | Aug 23, 2029 | Aug 23, 2029 | Common Stock | 360 | 360 | D |
| Restricted Stock UnitsF4 | — | Aug 23, 2026 | A | 360 | A | — | — | Common Stock | 360 | 360 | D |
| Stock OptionF5 | $341.31 | Aug 23, 2026 | A | 1,969 | A | — | — | Common Stock | 1,969 | 1,969 | D |
Explanation of responses
- F1Vesting of Restricted Stock Units pursuant to the Company's 2018 Omnibus Incentive Plan.
- F2Shares sold to pay taxes on vesting of previously issued restricted stock and/or performance share units.
- F3Award of Performance Share Units pursuant to the 2018 Omnibus Incentive Plan of the Company. These shares cliff vest at the end of a three year performance period with the ultimate number of shares ranging from 0 to 250% of the award based on achievement against Company performance metrics of the three year period.
- F4Grant of Restricted Stock Units pursuant to the 2018 Omnibus Incentive Plan of the Company which vests one-third per year on each anniversary of the date of the award.
- F5Premium Priced Stock Option with exercise price 10% above the closing market price on the date of grant. Option vests 25% per year on each anniversary of the date of the award for four years.